Vir Biotechnology Inc. (VIR) Announces CTO Departure

On January 24, 2025, Vir Biotechnology Inc. (NASDAQ: VIR) announced that Ann (Aine) M. Hanly, Ph.D., the Company’s Executive Vice President and Chief Technology Officer, will be leaving the Company on February 26, 2025. The Company has appointed Maninder Hora, Ph.D. to the role of Executive Vice President and Chief Technical Operations Officer, effective February 27, 2025, and Dr. Hora will assume Dr. Hanly’s responsibilities.

You May Also Be Interested In

• Boeing names Ryan Shedd as new SVP and controller
• Real and RE/MAX Holdings receive court approval for merger
• Cytek faces $56M damages award in Beckman Coulter patent case